REPAGLINIDE – Medication Overview
Repaglinide 1 mg is an oral medication manufactured by Life Max Cancer. It falls under the category of uncategorised medicines and is available in a strip packing type containing 10 tablets. The actual maximum retail price (MRP) of the medication is Rs. 103, but it is currently being offered at a discounted price of 55.5, representing a discount of 46.12%.
Active Ingredients
The active ingredient in Repaglinide 1 mg is repaglinide, a medication used to treat type 2 diabetes by helping the pancreas produce insulin more effectively.
Pharmacological Properties
Repaglinide belongs to a class of medications known as meglitinides. It works by stimulating the release of insulin from the pancreas, which helps lower blood sugar levels after meals.
Indications
Repaglinide is indicated for the management of type 2 diabetes mellitus in adults when diet, exercise, and weight reduction alone are not sufficient to control blood sugar levels.
Contraindications
Repaglinide should not be used in patients with type 1 diabetes, diabetic ketoacidosis, or a history of hypersensitivity to the drug or its components.
Dosage
The usual starting dose of Repaglinide is 0.5 mg taken before each main meal. The dose may be adjusted based on individual response to a maximum daily dose of 4 mg.
Side Effects
Common side effects of Repaglinide may include hypoglycemia (low blood sugar), weight gain, and gastrointestinal symptoms such as diarrhea or constipation.
Drug Interactions
Repaglinide may interact with certain medications such as gemfibrozil, clopidogrel, and some antifungal agents, leading to an increased risk of hypoglycemia or other adverse effects. It is important to consult a healthcare provider before starting or stopping any medications while taking Repaglinide.
Patient Counseling
Patients taking Repaglinide should be advised to monitor their blood sugar levels regularly, adhere to a healthy diet and exercise regimen, and be aware of the signs and symptoms of hypoglycemia. They should also inform their healthcare provider about any other medications or supplements they are taking to avoid drug interactions.
Clinical Evidence
Clinical studies have shown that Repaglinide is effective in lowering blood sugar levels in patients with type 2 diabetes when used as part of a comprehensive treatment plan that includes diet, exercise, and other medications as needed.
Frequently Asked Questions (FAQs)
1. Can Repaglinide be used to treat type 1 diabetes?
No, Repaglinide is specifically indicated for the management of type 2 diabetes mellitus and should not be used in patients with type 1 diabetes.
2. What should I do if I miss a dose of Repaglinide?
If you forget to take a dose of Repaglinide, skip the missed dose and take your next dose at the regular time. Do not double the dose to make up for a missed one.
3. Is it safe to drink alcohol while taking Repaglinide?
Alcohol can affect blood sugar levels and may also interact with Repaglinide, increasing the risk of side effects. It is recommended to limit or avoid alcohol consumption while taking this medication.
4. How long does it take for Repaglinide to start working?
Repaglinide usually starts working within 30 minutes of taking a dose and reaches its peak effect within 1 to 2 hours after ingestion.
5. Can Repaglinide cause weight gain?
Some patients may experience weight gain while taking Repaglinide, although not everyone will have this side effect. It is important to monitor weight changes and discuss any concerns with your healthcare provider.
6. What are the signs of hypoglycemia to watch out for while taking Repaglinide?
Symptoms of low blood sugar may include sweating, trembling, rapid heartbeat, confusion, dizziness, and hunger. It is essential to have a source of fast-acting sugar on hand to treat hypoglycemia if it occurs.
Keep in mind that this information is intended as a general guide, and specific recommendations may vary based on individual medical conditions. Always consult your healthcare provider for personalized advice and guidance on the use of Repaglinide or any other medication.
